TransCode Therapeutics, Inc. (RNAZ)
1.76
-0.13
(-6.88%)
USD |
NASDAQ |
Sep 09, 14:01
TransCode Therapeutics Price : 1.76 for Sept. 9, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 08, 2026 | 1.98 | 2.03 | 1.88 | 1.89 | 37787.00 |
| Sep 04, 2026 | 2.18 | 2.18 | 2.05 | 2.06 | 10622.00 |
| Sep 03, 2026 | 2.27 | 2.27 | 2.02 | 2.155 | 69966.00 |
| Sep 02, 2026 | 2.06 | 2.12 | 2.01 | 2.01 | 22515.00 |
| Sep 01, 2026 | 2.08 | 2.350 | 2.04 | 2.06 | 98171.00 |
| Aug 31, 2026 | 2.10 | 2.28 | 1.832 | 2.10 | 838251.0 |
| Aug 28, 2026 | 2.24 | 2.345 | 2.09 | 2.18 | 38032.00 |
| Aug 27, 2026 | 2.35 | 2.408 | 2.27 | 2.28 | 27617.00 |
| Aug 26, 2026 | 2.58 | 2.58 | 2.24 | 2.34 | 24255.00 |
| Aug 25, 2026 | 2.74 | 2.873 | 2.40 | 2.53 | 138123.0 |
| Aug 24, 2026 | 2.90 | 2.91 | 2.65 | 2.70 | 78327.00 |
| Aug 21, 2026 | 2.90 | 3.00 | 2.87 | 2.87 | 42178.00 |
| Aug 20, 2026 | 3.121 | 3.28 | 2.87 | 2.97 | 45694.00 |
| Aug 19, 2026 | 3.27 | 3.490 | 3.03 | 3.21 | 76126.00 |
| Aug 18, 2026 | 3.00 | 3.37 | 3.00 | 3.24 | 22064.00 |
| Aug 17, 2026 | 3.36 | 3.498 | 2.943 | 3.16 | 81257.00 |
| Aug 14, 2026 | 3.50 | 3.70 | 3.21 | 3.28 | 41009.00 |
| Aug 13, 2026 | 3.42 | 3.50 | 3.30 | 3.48 | 23982.00 |
| Aug 12, 2026 | 3.40 | 3.61 | 3.32 | 3.37 | 21581.00 |
| Aug 11, 2026 | 3.90 | 3.980 | 3.43 | 3.43 | 24118.00 |
| Aug 10, 2026 | 3.91 | 4.26 | 3.88 | 3.88 | 20136.00 |
| Aug 07, 2026 | 4.00 | 4.310 | 3.96 | 3.96 | 28588.00 |
| Aug 06, 2026 | 4.30 | 4.30 | 3.99 | 4.27 | 13386.00 |
| Aug 05, 2026 | 4.54 | 4.54 | 4.25 | 4.25 | 8373.00 |
| Aug 04, 2026 | 4.38 | 4.72 | 4.38 | 4.45 | 14482.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 83.67 |
| Oncolytics Biotech, Inc. | 0.805 |
| Sangamo Therapeutics, Inc. | 0.1609 |
| Sarepta Therapeutics, Inc. | 22.15 |
| Anixa Biosciences, Inc. | 2.82 |
Price Related Metrics
| Earnings Yield | -2.88K% |
| Market Cap | 1.780M |